Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Pharmacy and Medicines Management

There are pharmacy dispensaries at three hospitals within the Trust. These dispense medicines to patients for use on the wards and to take home (TTO) when they are discharged from hospital. They also dispense medicines for outpatients.

All medicines are currently included in the Trust's medicines formulary (a list of medicines approved for use within the Trust).

Oxford University Hospitals Formulary July 2021 (pdf, 2 MB)


JR Pharmacy

The dispensary is in the corridor from the main entrance on Level 2 of the John Radcliffe Hospital.

  • Monday to Friday: 8.00am - 5.00pm
  • Saturday and Sunday: 9.00am - 5.00pm
  • Tel: 01865 221502

Churchill Pharmacy

The dispensary is by the East Entrance of the Churchill Hospital (Car Park 4). You do not have to go in to the main building.

  • Monday to Friday: 9.00am - 5.00pm
  • Saturday and Sunday: 9.00am - 5.00pm
  • Tel: 01865 572153

Horton Pharmacy

The dispensary is located by the Oxford Road entrance of the Horton General Hospital. Enter through the Outpatient entrance sliding doors and turn right; it is a short distance along on the right hand side.

  • Monday to Friday: 9.00am - 5.00pm
  • Saturday and Sunday: 9.00am - 5.00pm
  • Tel: 01295 229007



B-Cell repopulation after Ocrelizumab in Multiple Sclerosis Patients (4858)

Cefazolin as second line treatment for invasive Methicillin-Susceptible Staphylococcus aureus infection in a UK cohort of patients

Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients

The standards treatment


A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care. Seizure: European Journal of Epilepsy 75 (2020) 153-164

Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes

Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care

Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK)

Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review (pdf)

Co-administration of multiple intravenous medicines: Intensive care nurses' views and perspectives


Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU